11.9K
Downloads
165
Episodes
Over 150+ Episodes. We speak to Pharma & Biotech Industry leaders and hear their stories of personal and professional growth. Perfect for both aspiring leaders and experienced individuals looking to help make a positive impact in the world of Clinical Research.
Episodes
Wednesday Feb 23, 2022
Wednesday Feb 23, 2022
This week James and Adam speak to Edward Olano Co-Founder & CEO and Murph McKeon CFO of Arrow DX.
Arrow Dx is combining Nanotechnology and Artificial Intelligence (AI) to create an inexpensive, sensitive test to screen early for non-alcoholic fatty liver disease (NAFLD).
Their aim is to provide physicians with an alternative to a liver biopsy that detects the disease too late. They are working to solve the lack of rapid, reliable, point-of-care, and inexpensive diagnostic devices by bringing faster, inexpensive and mobile testing for many other applications that require rapid response (e.g., epidemic/pandemics, public health crisis, early diagnosis for rising complex non-communicable diseases, testing in emergency rooms).
Tune in to hear how Arrow DX was founded and how it’s going.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.